Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam
NCT03601546 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-08-09
Summary
The purpose of this study is to evaluate the feasibility of implementing a cohort of patients with Hepatitis C in order to generate a larger cohort for future studies
Conditions
- Hepatitis C Infection
Interventions
- OTHER
-
Clinical examination
Blood test and patient interview as for standard patient care
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Didier Laureillard, MD · CHU Nimes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-13
- Primary Completion
- 2021-08-31
- Completion
- 2021-08-31
Countries
- France
- Vietnam
Study Locations
More Related Trials
-
Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C
NCT02826447 ·Status: UNKNOWN
-
Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients
NCT01197157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)
NCT05906459 ·Status: UNKNOWN
-
Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT05929963 ·Status: UNKNOWN
-
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT02574884 ·Status: COMPLETED ·Phase: NA
-
Factors Associated to Success of Hepatitis C Therapy
NCT00514111 ·Status: COMPLETED
-
Improving Inpatient Screening for Hepatitis C
NCT04525690 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomic Research in Korean Patients With Hepatitis C
NCT01453244 ·Status: COMPLETED
-
Direct Acting Agents in Hepatitis C Patients
NCT03145844 ·Status: COMPLETED
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)
NCT01276756 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
NCT01594554 ·Status: UNKNOWN
-
Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil
NCT04039698 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults
NCT00314054 ·Status: COMPLETED ·Phase: PHASE1
-
Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients
NCT00132210 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
NCT02753699 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
NCT03887637 ·Status: UNKNOWN
-
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
NCT01222611 ·Status: COMPLETED ·Phase: PHASE4
-
Qualification of Point-of-Care Assays for Management of HCV Patients
NCT02335320 ·Status: UNKNOWN
-
24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C
NCT01517308 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection
NCT00157534 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
NCT01771653 ·Status: COMPLETED
-
KP-Led Same Day HCV Test and Treat Study
NCT05479760 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study in Hepatitis C Patients With PHN121
NCT01052090 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.
NCT00671671 ·Status: COMPLETED ·Phase: PHASE1